Tumor necrosis factor α promoter polymorphisms influence the phenotypic expression of hereditary hemochromatosis

Blood

Volumn 97, Issue 12, 2001, Pages 3707-3712

  Fargion, Silvia ^a,b,c   Valenti, Luca ^a,b   Dongiovanni, Paola ^a,b   Scaccabarozzi, Anna ^a,b   Fracanzani, Anna Ludovica ^a,b   Taioli, Emanuela ^a,b   Mattioli, Michela ^a,b   Sampietro, Maurizio ^a,b   Fiorelli, Gemino ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c Stroke Unit Divisione di Granda   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; GENETIC POLYMORPHISM; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROMOTER REGION; SIDEROSIS;

EID: 0035877982     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V97.12.3707     Document Type: Article

References (42)

1. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet. 1996;13:399-408.
2. Piperno A, Sampietro M, Pietrangelo A, et al. Heterogeneity of hemochromatosis in Italy. Gastroenterology. 1998;114:996-1002.
3. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med. 1999;341:718-724.
4. Powell LW, Subramamiam VN, Yapp TR. Haemochromatosis in the new millennium. J Hepatol. 2000;32(suppl 1):48-62.
5. Torti SV, Kwak EL, Miller SC, et al. The molecular cloning and characterization of murine ferritin heavy chain, a tumor necrosis factor-inducible gene. J Biol Chem. 1988;263:12638-12644.
6. Tsuji Y, Miller LL, Miller SC, Torti SV, Torti FM. Tumor necrosis factor-α and interleukin 1-α regulate transferrin receptor in human diploid fibroblasts. J Biol Chem. 1991;266:7257-7261.
7. Alvarez-Hernandez X, Liceaga J, McKay IC, Brock JH. Induction of hypoferremia and modulation of macrophage iron metabolism by tumor necrosis factor. Lab Invest. 1989;61:319-324.
8. Moldawer LL, Marano MA, Wei H, et al. Cachectin/tumor necrosis factor-α alters red blood cell kinetics and induces anemia in vivo. FASEB J. 1989;3:1637-1643.
9. Wilson AG, di Giovine FS, Blakemore AIF, Duff GW. Single base polymorphism in the human tumour necrosis factor (α (TNF α) gene detectable by Ncol restriction of PCR product. Hum Mol Gen. 1992;1:353.
10. D'Alfonso S, Richiardi PM. A polymorphic variation in a putative regulation box of the TNF α promoter region. Immunogenetics. 1994;39:150-154.
11. Kroeger KM, Carville KS, Abraham IJ. The -308 tumor necrosis factor-α promoter polymorphism affects transcription. Mol Immunol. 1997;34:391-399.
12. Wilson AG, Symon JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factors promoter on transcriptional activity. Proc Natl Acad Sci U S A. 1997;94:3195-3199.
13. Ruwende C, McGuire W, Coleman E, et al. Association of a tumor necrosis factor promoter polymorphism with susceptibility to pulmonary tuberculosis [abstract]. Clin Sci. 1996;90:3P.
14. Grove J, Daly AK, Bassendine MF, Day CP. Association of tumor necrosis factor promoter polymorphism with susceptibility to alcoholic steatohepatitis. Hepatology. 1997;273:1516-1517.
15. Kaluza W, Reuss E, Grossman S, et al. Different transcriptional activity and in vitro TNF-α production in psoriasis patients carrying the TNF-α 238A promoter polymorphism. J Invest Dermatol. 2000;114:1180-1183.
16. Jones DE, Watt FE, Grove J, et al. Tumour necrosis factor-α promoter polymorphisms in primary biliary cirrhosis. J Hepatol. 1999;30:232-236.
17. Tanaka A, Quaranta S, Mattalia A, et al. The tumor necrosis factor-α promoter correlates with progression of primary biliary cirrhosis. J Hepatol. 1999;30:826-829.
18. Bernal W, Donaldson P, Underhill J, Williams W, Williams R. Tumor necrosis factor genomic polymorphism and outcome of acetaminophen (paracetamol)-induced liver failure. J Hepatol. 1998;29:53-59.
19. Cookson S, Constantini PK, Clare M, et al. Frequency and nature of cytokine gene polymorphism in type 1 autoimmune hepatitis. Hepatology. 1999;30:851-856.
20. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenfelde KH, Rittner C. A tumor necrosis factor-α (TNF-α) promoter polymorphism is associated with chronic hepatitis B infection. Clin Exp Immunol. 1998;111:579-582.
21. Hohler T, Kruger A, Gerken G, Schneider PM, Meyer zum Buschenfelde KH, Rittner C. Tumor necrosis factor promoter polymorphism at position -238 is associated with chronic active hepatitis C infection. J Med Virol. 1998;54:173-177.
22. Rosen HR, Lentz JJ, Rose SL, et al. Donor polymorphism of tumor necrosis factor gene: relationship with variable severity of hepatitis C recurrence after liver transplantation. Transplantation. 1999;68:1898-1902.
23. Flanagan PR, Lam D, Banerjee D, Valberg LS. Ferritin release by mononuclear cells in hereditary hemochromatosis. J Lab Clin Med. 1989;113:145-150.
24. Fillet G, Beguin Y, Baldelli L. Model of reticuloendothelial iron metabolism in humans: abnormal behavior in idiopathic hemochromatosis and in inflammation. Blood. 1989;74:844-851.
25. Cairo G, Recaicati S, Montosi G, Castrusini E, Conte D, Pietrangelo A. Inappropriately high iron regulatory protein activity in monocytes of patients with genetic hemochromatosis. Blood. 1997;89:2546-2453.
26. Miller LL, Miller SC, Torti SV, Tsuji Y, Torti FM. Iron-independent induction of ferritin H chain by tumor necrosis factor. Proc Natl Acad Sci U S A. 1991;88:4946-4950.
27. Fahmy M, Young SP. Modulation of iron metabolism in monocyte cell line U937 by inflammatory cytokines: changes in transferrin uptake, iron handling and ferritin mRNA. Biochem J. 1993;296:175-181.
28. Gordeuk VR, Ballou S, Lozanski G, Brittenham GM. Decreased concentrations of tumor necrosis factor-α in supernatants of monocytes from homozygotes for hereditary hemochromatosis. Blood. 1992;79:1855-1860.
29. Scheuer PJ, Williams R, Muir AR. Hepatic pathology in relatives of patients with hemochromatosis. J Pathol Bacteriol. 1962;84:53-64.
30. Barry M, Sherlock S. Measurement of liver iron concentration in needle biopsy specimens. Lancet. 1971;1:100-103.
31. Piperno A, Arosio A, Fargion S, et al. The ancestral hemochromatosis haplotype is associated with severe phenotype expression in Italian patients. Hepatology. 1996;24:43-46.
32. Recalcati S, Pometta R, Levi S, Conte D, Cairo G. Response of monocyte iron regulatory protein activity to inflammation: abnormal behavior in genetic hemochromatosis. Blood. 1998;91:2565-2572.
33. Scaccabarozzi A, Arosio P, Weiss G, et al. Relationship between TNF α and iron metabolism in differentiating human monocytic TNP-1 cells. Br J Haematol. 2000;110:978-984.
34. Hirayama M, Kohgo Y, Kondo H, et al. Regulation of iron metabolism in HepG2 cells: a possible role for cytokines in the hepatic deposit of iron. Hepatology. 1993;18:874-880.
35. Tran TN, Eubanks SK, Schaffer KJ, Zhou CY, Linder MC. Secretion of ferritin by rat hepatoma ceils and its regulation by inflammatory cytokines and iron. Blood. 1997;90:4979-4986.
36. Han O, Wood RJ. Pro-inflammatory cytokines increase the expression of the HFE protein in human intestinal cells. World Congress of Iron Metabolism; May 23-28, 1999; Sorrento, Italy. Abstract 216.
37. Montosi G, Paglia P, Garuti C, et al. Wild-type HFE protein normalizes transferrin iron accumulation in macrophages from subjects with hereditary hemochromatosis. Blood. 2000;96:1125-1129.
38. Weiss G, Wachter H, Fuchs D. Linkage of cell-mediated immunity to iron metabolism. Immunol Today. 1995;16:495-500.
39. Ten Elshof AE, Brittenham GM, Chorney KA, et al. γδ Intraepithelial lymphocytes drive tumor necrosis factor-α response to intestinal iron challenge: relevance to hemochromatosis. Immunol Rev. 1999;167:223-232.
40. Pociot F, D'Alfonso S, Compasso S, Scorza R, Richiardi PM. Functional analysis of a new polymorphism in the human TNF-α promoter. Scand J Immunol. 1995;42:501-504.
41. Kroeger KM, Steer JH, Joyce DA, Abraham LJ. Effects of stimulus and cell type on the expression of the -308 tumour necrosis factor promoter polymorphism. Cytokine. 2000;12:110-119.
42. Takehara T, Hayashi N, Mita E, et al. Delayed Fas-mediated hepatocyte apoptosis during liver regeneration in mice: hepatoprotective role of TNF α. Hepatology. 1998;27:1643-1651.